Joan Korth-Bradley, Pharmd, Phd Email and Phone Number
Extensive experience, from A (amiodarone) to Z (Zosyn), designing and implementing the PK/PD portions of clinical development plans including: integration of preclinical and clinical findings, protocol design, execution, and analysis using state of the art methods, summarizing and interpreting results, preparation of study reports, summary documents, publications and presentations, to make sure in the end that the right dose is given to the right patient. Experienced in life-cycle development of new dosage forms, which supports continued improvement of proven therapies.Experience with successful development of both small molecules and therapeutic proteins, using variety of software packages supporting Monte-Carlo simulation, optimal experimental design, noncompartmental, population pharmacokinetic, pharmacodynamic analyses and model development.Project Management experience has provided an intergrated understanding of drug development and Medical Communication experience provided clear view of product-specific information needed by health care providers using pharmaceutical products.Specialties: PK/PD components of drug development; special populations; integration, interpretation, and communication of PK/PD information.
-
Distinguished ScientistVivpro Corp Apr 2024 - PresentLansdale, Pa, Us
-
Senior Director, Clinical PharmacokineticsPfizer Oct 2009 - Apr 2024New York, New York, UsContributes to interdepartmental team (rare diseases) objectives through contribution of clinical pharmacokinetic/pharmacodynamic strategy, analyses, and interpretation, preparation of clinical pharmacology regulatory submissions and responses.Coach and manage the activities of other clinical pharmacology leads in multiple therapeutic areas.Serves as reviewer and editorial board member for several journals and professional organizations. -
Senior Director, Clinical Pharmacokinetics,Pfizer 2005 - Oct 2009New York, New York, UsContributes to interdepartmental team (anti-infective and anti-inflammatory) objectives through contribution of clinical pharmacokinetic/pharmacodynamic strategy, analyses, and interpretation, preparation of clinical pharmacology regulatory submissions and responses.Serves as reviewer and editorial board member for several journals and professional organizations.
-
Director, Project ManagementPfizer Apr 2003 - Feb 2005New York, New York, UsProvided strategic leadership for interdepartmental team responsible for developing antibiotics and continuing life-cycle product improvement as well as managed strategic alliance with partner for development team responsible for developing product for use in developing countries.
-
Director, Medical CommunicationsPfizer Jan 2002 - Mar 2003New York, New York, UsManaged specialty products product information team (5 direct reports) with responsibility for 7 core products in addition to approximately 20 additional legacy products; prepared and approved preparation of standard response letters for core and legacy products; provided product information to medical affairs, affiliate medication information groups, product marketing and legal groups in addition to health care providers; served as reviewer and editorial board member for several journals and professional organizations
-
Director, Clinical PharmacokineticsPfizer Jan 1998 - Dec 2001New York, New York, UsManager for oncology/antiinflammatory pharmacokinetics group (5 direct reports) with responsibility for 6 to 10 compounds in phase I through post-marketing; provide pharmacokinetic/pharmacology information to a wide variety of groups including preclinical, clinical, marketing, legal, safety and surveillance and product information as well as US, Canadian, European and Japanese regulatory authorities; planned and executed clinical pharmacokinetic development plan (IND through registration) for 2 biological products; planned and executed clinical pharmacokinetic components of sNDAs, including application for pediatric exclusivity, for antibiotic and anti-inflammatory products; performed pharmacokinetic and pharmacodynamic analyses using a wide variety of software programs and techniques, including NONMEM, SAS, WinNONLIN and ADAPT; served as reviewer and editorial board member for several journals and professional organizations
-
Associate Director, Clinical PharmacokineticsPfizer Jan 1995 - Dec 1997New York, New York, Us
-
Assistant Director, Clinical PharmacokineticsPfizer Sep 1991 - Dec 1994New York, New York, Us
-
Assistant ProfessorUniversity Of Alberta Sep 1984 - Aug 1986Edmonton, Ab, Ca
Joan Korth-Bradley, Pharmd, Phd Education Details
-
The University Of Texas At AustinPharmacokinetics -
The University Of Texas At AustinPediatric Clinical Pharmacy
-
University Of MinnesotaPharmacy
-
University Of TorontoPharmacy
Frequently Asked Questions about Joan Korth-Bradley, Pharmd, Phd
What company does Joan Korth-Bradley, Pharmd, Phd work for?
Joan Korth-Bradley, Pharmd, Phd works for Vivpro Corp
What is Joan Korth-Bradley, Pharmd, Phd's role at the current company?
Joan Korth-Bradley, Pharmd, Phd's current role is Clinical Pharmacology | Drug Development | Regulatory Strategy.
What schools did Joan Korth-Bradley, Pharmd, Phd attend?
Joan Korth-Bradley, Pharmd, Phd attended The University Of Texas At Austin, The University Of Texas At Austin, University Of Minnesota, University Of Toronto.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial